주요 콘텐츠로 건너뛰기
번역 진행 중 — 귀하의 언어 버전을 준비하는 동안 이 콘텐츠가 영어로 표시됩니다.

Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!

Healthcare
United States
July 16, 2026에 시작됨

1,700 Americans will die from cancer today. 70 every single hour. Professor Thomas Seyfried says it doesn't have to be this way, and that mainstream oncology has misunderstood cancer for 100 years. Thomas Seyfried, PhD, is a professor of biology at Boston College and one of the world's leading researchers on the metabolic origins of cancer. He is author of the book 'Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer' and co-developer of the Glucose Ketone Index...

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
7 투표할 진술 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 7/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 게시자: admin Jul 16, 2026
Seyfried's claims about the shortcomings of mainstream oncology need thorough scrutiny. We must ensure that any new theories are supported by robust clinical evidence before making significant changes to treatment protocols.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 게시자: admin Jul 16, 2026
Professor Thomas Seyfried's research on the metabolic origins of cancer challenges long-held beliefs in oncology. By focusing on the metabolic aspects, we may discover innovative therapies that can significantly improve cancer treatment and patient outcomes.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 게시자: admin Jul 16, 2026
As a patient, I want to understand all possible approaches to treating cancer. It's important to critically evaluate Seyfried's research alongside established methods to determine the best options for our health.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 게시자: admin Jul 16, 2026
If Seyfried's research leads to groundbreaking new treatments, it is essential for both medical professionals and patients to be aware of these developments. Ignoring innovative approaches could mean missing out on potential lifesaving therapies.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 게시자: admin Jul 16, 2026
Despite Seyfried's passionate advocacy, the medical community relies on comprehensive data from various sources. We must remain cautious about adopting new treatments without substantial empirical support, as patient safety is paramount.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 게시자: admin Jul 16, 2026
Considering the high mortality rate of cancer in America, it might be time to reassess how we approach its treatment. Are we adequately exploring alternative research like Seyfried's, or are we too entrenched in conventional methods?

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 게시자: admin Jul 16, 2026
Seyfried's emphasis on metabolic therapy highlights an overlooked aspect of cancer research. By advocating for patient awareness of these alternative theories, we could empower individuals to take a more active role in their treatment choices.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us